Body Composition As a Prognostic Factor in Cholangiocarcinoma: a Meta-analysis

Overview

Journal Nutr J

Publisher Biomed Central

Specialty Nutritional Sciences

Date 2024 Nov 16

PMID 39548545

Authors

Lilong Zhang

Kunpeng Wang

Rongqiang Liu

Tianrui Kuang

Chen Chen

Feng Yao

Weixing Wang

Affiliations

Soon will be listed here.

Abstract

This investigation seeks to scrutinize the relationships between body composition metrics and the clinical outcomes observed in patients with cholangiocarcinoma (CCA). A comprehensive exploration was conducted across three prominent online databases: Embase, PubMed, and the Cochrane Library. This endeavor spanned the entirety of each database up to the cutoff date of September 29, 2023. To evaluate the quality of the included studies, the Newcastle-Ottawa scale was employed. This comprehensive analysis included a total of 26 articles with a combined patient cohort of 4398 individuals. The results demonstrated that CCA patients with low skeletal muscle index (SMI) had significantly inferior OS (HR: 1.93, p < 0.001) and RFS (HR: 2.02, p < 0.001), as well as a higher incidence of postoperative complications (OR: 1.69, 95% CI: 1.20-2.38, p < 0.001) compared to those with high SMI. The presence of sarcopenia in CCA patients was significantly related to poorer OS (HR: 1.96, p < 0.001) and RFS (HR: 2.05, p < 0.001), and a higher rate of postoperative complications (OR: 1.39, p = 0.049) in comparison to those without sarcopenia. Moreover, lower psoas muscle index (PMI) and myosteatosis were associated with shorter OS (PMI, HR: 1.56, p < 0.001; myosteatosis, HR: 1.49, p = 0.001) and RFS (PMI, HR: 2.16, p < 0.001; myosteatosis, HR: 1.35, p = 0.023). Our findings highlight incorporating body composition screening into clinical practice can help develop treatment strategies and optimize perioperative care, potentially improving patient outcomes.

References

Yasuta S, Sugimoto M, Kudo M, Kobayashi S, Takahashi S, Konishi M . Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma. BMC Cancer. 2022; 22(1):1358. PMC: 9795591. DOI: 10.1186/s12885-022-10453-2. View

Zhou G, Bao H, Zeng Q, Hu W, Zhang Q . Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study. Int J Clin Exp Med. 2016; 8(10):18245-54. PMC: 4694326. View

Clugston A, Paterson H, Yuill K, Garden O, Parks R . Nutritional risk index predicts a high-risk population in patients with obstructive jaundice. Clin Nutr. 2006; 25(6):949-54. DOI: 10.1016/j.clnu.2006.03.001. View

Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y . The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr. 2020; 40(5):3552-3558. DOI: 10.1016/j.clnu.2020.12.011. View

Pedersen B, Febbraio M . Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012; 8(8):457-65. DOI: 10.1038/nrendo.2012.49. View

Kitano Y, Yamashita Y, Saito Y, Nakagawa S, Okabe H, Imai K . Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma. World J Surg. 2019; 43(9):2271-2280. DOI: 10.1007/s00268-019-05013-y. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Umetsu S, Wakiya T, Ishido K, Kudo D, Kimura N, Miura T . Effect of sarcopenia on the outcomes after pancreaticoduodenectomy for distal cholangiocarcinoma. ANZ J Surg. 2018; 88(9):E654-E658. DOI: 10.1111/ans.14304. View

Zhang L, Kuang T, Chai D, Deng W, Wang P, Wang W . The Use of Antibiotics During Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Advanced Esophagogastric Cancer. Int Immunopharmacol. 2023; 119:110200. DOI: 10.1016/j.intimp.2023.110200. View

10.

Deng L, Wang Y, Zhao J, Tong Y, Zhang S, Jin C . The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study. Eur J Surg Oncol. 2020; 47(3 Pt B):603-612. DOI: 10.1016/j.ejso.2020.09.002. View

11.

Suriano F, Van Hul M, Cani P . Gut microbiota and regulation of myokine-adipokine function. Curr Opin Pharmacol. 2020; 52:9-17. DOI: 10.1016/j.coph.2020.03.006. View

12.

Blair C, Robien K, Inoue-Choi M, Rahn W, Lazovich D . Physical inactivity and risk of poor quality of life among elderly cancer survivors compared to women without cancer: the Iowa Women's Health Study. J Cancer Surviv. 2015; 10(1):103-12. PMC: 4876041. DOI: 10.1007/s11764-015-0456-9. View

13.

Zhang J, Ding Y, Yan H, Zhou C, Liu J, Liu S . Skeletal-muscle index predicts survival after percutaneous transhepatic biliary drainage for obstructive jaundice due to perihilar cholangiocarcinoma. Surg Endosc. 2020; 35(11):6073-6080. DOI: 10.1007/s00464-020-08099-x. View

14.

Gamboa A, Maithel S . The Landmark Series: Gallbladder Cancer. Ann Surg Oncol. 2020; 27(8):2846-2858. DOI: 10.1245/s10434-020-08654-9. View

15.

Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S . Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016; 46(10):951-63. DOI: 10.1111/hepr.12774. View

16.

Zhao Z, Bo Z, Ye N, Dong Y, Xu Y, Wang B . Impact of sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: A multicentre cohort study. Liver Int. 2023; 44(1):155-168. DOI: 10.1111/liv.15757. View

17.

Taniai T, Haruki K, Yanagaki M, Igarashi Y, Furukawa K, Onda S . Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surg Today. 2022; 53(1):82-89. DOI: 10.1007/s00595-022-02550-3. View

18.

Li H, Dai J, Lan T, Liu H, Wang J, Cai B . Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection. Clin Nutr. 2021; 40(6):3891-3900. DOI: 10.1016/j.clnu.2021.04.038. View

19.

Dodson S, Baracos V, Jatoi A, Evans W, Cella D, Dalton J . Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2010; 62:265-79. DOI: 10.1146/annurev-med-061509-131248. View

20.

Valle J, Vogel A, Denlinger C, He A, Bai L, Orlova R . Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. Lancet Oncol. 2021; 22(10):1468-1482. DOI: 10.1016/S1470-2045(21)00409-5. View